EU Exit Partnerships
The UK government’s funding Guarantee includes Horizon 2020 (H2020) grants awarded through an open and competitive process through Public-to-Public Partnerships (P2Ps) and Public-Private Partnerships (PPPs) that make up about 25 percent of the overall H2020 budget. These cover:
- Joint Technology Initiatives (JTIs; also referred to as Article 187 Joint Undertakings)
- Contractual Public Private Partnerships (cPPPs)
- Future Emerging Technology Flagships (FET-Flagships)
- Article 185s
- European Innovation and Industrial Technology Knowledge and Innovate Communities (EIT-KICs)
- European Research Area Network Cofunds (ERA-Net Cofunds)
- European Joint Programme Cofunds (EJP Cofunds)
- Joint Programming Initiatives (JPIs)
UK partnership grant beneficiaries should continue to register grants on the UKRI portal to ensure they receive updates from UKRI. This is with the exception of one of the three Article 185 programmes, EUROSTARS2. No action needs to be taken for continuation of these grants as they are already managed directly by Innovate UK. UK Research and Innovation (UKRI) will contact beneficiaries through the H2020 portal with information on the next steps they need to take to access guarantee funding, if it is required.
Many of these grants are awarded through different processes to those used on the majority of H2020 grants and therefore the documentation used to access the Guarantee also varies.
UK beneficiaries in Joint Technology Initiative (JTIs, also referred to as Article 187 Joint Undertakings) or cPPP grants should follow the standard process for accessing the funding Guarantee, including providing the same documentation.
For all other programmes, there are modifications to the standard process for accessing the funding Guarantee, notably in the documentation that is required in step 2. Further information and the documentation that needs to be provided is below, along with a summary table:
The European Commission administers grants for FET-Flagship grants through H2020 calls, however, these differ depending on the FET-Flagship.
The Human Brain Project and Graphene Flagships utilise Framework Partnership Agreements (FPAs) and Specific Grant Agreements (SGAs). Beneficiaries within these programmes will need to provide the SGA as their grant agreement. There is no need to submit the FPA.
The Quantum Flagship uses standard H2020 grant agreements and does not use FPAs or SGAs. Therefore, UK beneficiaries in Quantum Flagship grants should follow the standard process for access the funding Guarantee.
UK beneficiaries in Coordination and Support Actions (CSAs) for the preparation of new FET-Flagships should follow the standard process for access the funding Guarantee.
UK beneficiaries in ERA-Net Cofunds associated with the FET-Flagships should follow the process described below for ERA-Net Cofunds.
There are three Article 185 programmes that have active UK engagement: The European & Developing Countries Clinical Trials Partnership (EDCTP2), European Metrology Programme for Innovation and Research (EMPIR), and EUROSTARS2. Each operates differently and as a result, UKRI’s delivery of the UK government’s Guarantee is tailored to each Article 185 as described below:
The current funding arrangement for EDCTP2 is via a ‘common pot’ consisting of contributions from multiple funding sources, including H2020. If the UK leaves the EU without a deal, then the H2020 portion of EDCTP2 grants awarded through an open and competitive process is covered by the UK government’s Guarantee.
Due to the complexity of the ‘common pot’ funding, further details of how the guarantee will be delivered to UK beneficiaries will be published should the UK leave the EU without a deal.
UK grant holders in the EMPIR programme should follow the standard process, noting, however, that grant agreements and financial documentation will be issued by EUROMET rather than directly by the European Commission.
Projects under the EUROSTARS2 programme are already managed directly by Innovate UK (the UK funding partner in EUROSTARS2). Consequently, under a no-deal exit individual EUROSTARS2 grant holders do not need to take steps to access the Guarantee as this will be done by Innovate UK as the grant manager. Existing EUROSTARS2 grants held with Innovate UK will be continue as they do now.
There are eight EIT-KICs each of which operates via its own Headquarters and uses slightly different grant-awarding processes to each other. H2020 grant funding that is awarded to UK beneficiaries through an open and competitive process and the KICs’ usual annual business plan approval process is covered by the Guarantee.
To evidence a claim for Guarantee grant funding, UK beneficiaries will have to supply all three levels of grant agreement used by the KICs. These are the Framework Partnership Agreement (FPA), Specific Grant Agreement (SGA), and an individual grant agreement between the KIC and the beneficiary. This last agreement is referred to by different names, depending on the KIC, e.g. Task Confirmation Letter, Project Grant Agreement, Individual Grant Agreement, Internal Agreement Grant.
As with all Guarantee grant funding, only the H2020 portion of grants awarded to UK partners by the KICs is covered by the UK government’s Guarantee. Any financial or in-kind contributions leveraged by the H2020 funding should continue to be made.
UK partners in KICs should continue to pay their membership fees as determined by the individual KIC.
Guarantee funding will be administered at the level of the UK beneficiary/beneficiaries named on the ERA-Net Cofund Grant Agreement with the European Commission, rather than at the level of the individual research projects awarded through ERA-Net Cofund calls. These beneficiaries are typically, but not exclusively, funding agencies or government bodies.
For ERA-Net Cofunds that have completed the co-funded call and the distribution of EC funds is known at the point of EU Exit, the Guarantee will cover all H2020 grant funds allocated to the UK beneficiary through an open and competitive process.
In addition to the Grant Agreement, UK beneficiaries will have to provide supplementary evidence to demonstrate the distribution of European Commission funds, both for the contribution to the co-funded call and for any other activities undertaken by the UK beneficiary. This can be in the form of the Consortium Agreement and any internal documentation/reporting within the Consortium.
Updated information for ERA-Net Cofunds that have been awarded before exit but have not yet completed their co-funded call will be published shortly.
UKRI is aware that the different EJP Cofunds operate in different ways, however, the principle stands that the UK government’s Guarantee covers Horizon 2020 EJP Cofunds grants awarded through an open and competitive process.
Some EJP Cofund consortia do not distribute the full amount of H2020 funding among the beneficiaries at the outset of the programme; instead, a proportion of funding is retained to be allocated throughout the programme.
UKRI will deliver Guarantee funding based on the amount that can be evidenced as committed to the UK beneficiary at the point of EU Exit. In addition to the grant agreement, UK beneficiaries will also have to submit evidence of the current status of funding distribution within the EJP Cofund, e.g. a consortium agreement and/or annual work plans and/or internal documentation within the consortium.
Should there be a future allocation of funding, within the original EJP Cofund funding agreement, UK beneficiaries will be able to apply for a post-award amendment to their UKRI grant.
There are no specific grant types associated with Joint Programming Initiatives, as these are Member State-led programmes. However, many receive support through H2020, in particular via Coordination and Support Actions (CSAs) to facilitate the secretariat function of JPIs, and ERA-Net Cofunds. UK participation in these Horizon 2020 grants awarded through an open and competitive process is covered by the Guarantee, and beneficiaries should follow the processes specific to their grant type, e.g. standard process for CSAs or the process described above for ERA-Net Cofunds.
The table below summarises the differences from the standard checklist of documentation, where applicable, for each partnership type.
|Partnership||Difference from Standard Checklist of Documentation|
|Joint Technology Initiatives (JTIs; also referred to as Article 187 Joint Undertakings)||No difference from standard checklist|
|Contractual Public Private Partnerships (cPPPs)||No difference from standard checklist|
|Future and Emerging Technologies (FET) Flagships||
For Human Brain Project and Graphene Flagships, use Specific Grant Agreement.
For Quantum Flagship and Coordination and Support Actions (CSAs), no difference from standard checklist
For ERA-Net Cofunds related to FET Flagships, follow guidance for ERA-Net Cofunds.
|Article 185 – European and Developing Countries Clinical Trials Partnership (EDCTP2)||Process will be confirmed should the UK leave the EU without a deal.|
|Article 185 – European Metrology Programme for Innovation and Research (EMPIR)||Documents from the standard checklist are required, however Grant Agreement and financial documentation will be issued by EUROMET, rather than the European Commission.|
|European Institute of Innovation and Technology Knowledge and Innovation Communities (EIT KICs)||
The following EIT-KIC documents should replace the signed grant agreement in the standard checklist:
|European Research Area Network Cofunds (ERA-Net Cofunds)||
Additional documentation to demonstrate the distribution of H2020 funds:
|European Joint Programme Cofunds (EJP Cofunds)||
If full allocation of funding to UK beneficiary is not known, additional documentation to provide evidence of known allocation of budget at point of exit
|Joint Programming initiatives (JPIs)||
For Coordination and Support Actions (CSAs), no difference from standard checklist
For ERA-Net Cofunds related to JPIs, follow guidance for ERA-Net Cofunds.
Further details on partnerships can be found on EU's Partnerships with Industry and Member States page.
If you have a question that is not answered here please email: EUGrantsFunding@ukri.org